According to recent studies, the CD4+CD25lowGITR+ cell is a novel human CD4+ T-cell population with regulatory activity and expanded in patients with Sjögren’s syndrome or SLE [39,40,41]; the results of these studies provide new insight for our follow-up study. This evidence concerns the gene CD4 and Sjogren syndrome.